0000899243-19-009894.txt : 20190403 0000899243-19-009894.hdr.sgml : 20190403 20190403202210 ACCESSION NUMBER: 0000899243-19-009894 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190402 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sigal Nolan Howard CENTRAL INDEX KEY: 0001323291 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 19730906 MAIL ADDRESS: STREET 1: 941 BERRY AVENUE CITY: LOS ALTOS STATE: CA ZIP: 94024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-02 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001323291 Sigal Nolan Howard C/O AILERON THERAPEUTICS, INC. 490 ARSENAL WAY WATERTOWN MA 02472 1 0 0 0 Stock Option (right to buy) 1.82 2019-04-02 4 A 0 20000 0.00 A 2029-04-01 Common Stock 20000 20000 D This option was granted on April 2, 2019. The shares underlying the option are scheduled to vest in equal annual installments over three years from April 2, 2019. /s/ Nolan Howard Sigal 2019-04-03